iBio Announces Production of Biosimilar Rituximab with its iBioLaunch™ Technology PR Newswire (press release) ... production of biotherapeutic proteins and vaccine antigens in whole green plants has been used to produce a functional monoclonal antibody copy of rituximab, used in the medical treatment of lymphomas, autoimmune diseases, and transplant rejection. ... |
